Ondine Biomedical Inc. announces £3 million fundraising initiative
LONDON: Ondine Biomedical Inc., a Canadian life sciences company listed on AIM (OBI), has announced a significant fundraising effort to secure at least £3 million (C$5.15 million) from mainly existing shareholders. The initiative includes a placement and a subscription, aiming…